These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858 [TBL] [Abstract][Full Text] [Related]
45. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019 [TBL] [Abstract][Full Text] [Related]
46. [Detection of early neoplasia in Barrett's oesophagus: focus attention on index endoscopy in short-segment-Barrett's oesophagus with random biopsies]. Behrens A; Pech O; Wuthnow E; Manner H; Pohl J; May A; Ell C Z Gastroenterol; 2015 Jun; 53(6):568-72. PubMed ID: 26075367 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Ngamruengphong S; Sharma VK; Das A Gastrointest Endosc; 2009 May; 69(6):1021-8. PubMed ID: 19215918 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus with enhanced magnification endoscopy. Mayinger B; Oezturk Y; Stolte M; Faller G; Benninger J; Schwab D; Maiss J; Hahn EG; Muehldorfer S Scand J Gastroenterol; 2006 Mar; 41(3):349-56. PubMed ID: 16497625 [TBL] [Abstract][Full Text] [Related]
49. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218 [TBL] [Abstract][Full Text] [Related]
50. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
51. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Cameron AJ; Carpenter HA Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304 [TBL] [Abstract][Full Text] [Related]
52. Stratification of the dysplasia and neoplasia risk using autofluorescence endoscopic surveillance of Barrett's esophagus. Latos W; Bugaj AM; Sieroń A; Kawczyk-Krupka A Photodiagnosis Photodyn Ther; 2019 Mar; 25():285-291. PubMed ID: 30648638 [TBL] [Abstract][Full Text] [Related]
53. A preliminary feasibility study: Narrow-band imaging targeted versus standard white light endoscopy non-targeted biopsies in a surveillance Barrett's population. Pascarenco OD; Coroş MF; Pascarenco G; Boeriu AM; Draşovean SC; Onişor DM; Brusnic O; Dobru D Dig Liver Dis; 2016 Sep; 48(9):1048-53. PubMed ID: 27246796 [TBL] [Abstract][Full Text] [Related]
54. Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett's esophagus in Japanese patients without Helicobacter pylori infection. Yagi K; Nakamura A; Sekine A Gastrointest Endosc; 2003 Aug; 58(2):189-95. PubMed ID: 12872084 [TBL] [Abstract][Full Text] [Related]
55. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related]
56. [Does the criterium of positivity for the immunohistochemical analysis of p53 in the confirmation of Barrett's dysplasia make any difference?]. Lopes CV; Pereira-Lima JC; Hartmann AA; Tonelotto E; Salgado K Arq Gastroenterol; 2005; 42(4):233-8. PubMed ID: 16444378 [TBL] [Abstract][Full Text] [Related]
57. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Isenberg G; Sivak MV; Chak A; Wong RC; Willis JE; Wolf B; Rowland DY; Das A; Rollins A Gastrointest Endosc; 2005 Dec; 62(6):825-31. PubMed ID: 16301020 [TBL] [Abstract][Full Text] [Related]
58. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes. Shaheen NJ; Spechler SJ Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482 [No Abstract] [Full Text] [Related]
59. Dysplasia detection rate of confirmatory EGD in nondysplastic Barrett's esophagus. Abdalla M; Dhanekula R; Greenspan M; Mobarhan S; Patil A; Jakate S; Giusto D; Silva R; Li H; Melson J Dis Esophagus; 2014 Aug; 27(6):505-10. PubMed ID: 23020509 [TBL] [Abstract][Full Text] [Related]